154 related articles for article (PubMed ID: 34127813)
21. The transcription factor Lef1 switches partners from β-catenin to Smad3 during muscle stem cell quiescence.
Aloysius A; DasGupta R; Dhawan J
Sci Signal; 2018 Jul; 11(540):. PubMed ID: 30042129
[TBL] [Abstract][Full Text] [Related]
22. Hepatocyte growth factor activates Wnt pathway by transcriptional activation of LEF1 to facilitate tumor invasion.
Huang FI; Chen YL; Chang CN; Yuan RH; Jeng YM
Carcinogenesis; 2012 Jun; 33(6):1142-8. PubMed ID: 22436613
[TBL] [Abstract][Full Text] [Related]
23. Knockdown of lymphoid enhancer factor 1 inhibits colon cancer progression in vitro and in vivo.
Wang WJ; Yao Y; Jiang LL; Hu TH; Ma JQ; Liao ZJ; Yao JT; Li DF; Wang SH; Nan KJ
PLoS One; 2013; 8(10):e76596. PubMed ID: 24098538
[TBL] [Abstract][Full Text] [Related]
24. Asporin promotes cell proliferation via interacting with PSMD2 in gastric cancer.
Zhang Z; Li H; Zhao Y; Guo Q; Yu Y; Zhu S; Zhang S; Min L; Li P
Front Biosci (Landmark Ed); 2019 Jun; 24(6):1178-1189. PubMed ID: 31136974
[TBL] [Abstract][Full Text] [Related]
25. ERG is a critical regulator of Wnt/LEF1 signaling in prostate cancer.
Wu L; Zhao JC; Kim J; Jin HJ; Wang CY; Yu J
Cancer Res; 2013 Oct; 73(19):6068-79. PubMed ID: 23913826
[TBL] [Abstract][Full Text] [Related]
26. Asporin participates in gastric cancer cell growth and migration by influencing EGF receptor signaling.
Ding Q; Zhang M; Liu C
Oncol Rep; 2015 Apr; 33(4):1783-90. PubMed ID: 25673058
[TBL] [Abstract][Full Text] [Related]
27. Effects of microRNA-708 on Epithelial-Mesenchymal Transition, Cell Proliferation and Apoptosis in Melanoma Cells by Targeting LEF1 through the Wnt Signaling Pathway.
Song XF; Wang QH; Huo R
Pathol Oncol Res; 2019 Jan; 25(1):377-389. PubMed ID: 29138985
[TBL] [Abstract][Full Text] [Related]
28. Lef1 regulates COX-2 transcription in chondrocytes.
Yun K; Im SH
Biochem Biophys Res Commun; 2007 Dec; 364(2):270-5. PubMed ID: 17945188
[TBL] [Abstract][Full Text] [Related]
29. Precision medicine-guided co-delivery of ASPN siRNA and oxaliplatin by nanoparticles to overcome chemoresistance of colorectal cancer.
Huang CZ; Zhou Y; Tong QS; Duan QJ; Zhang Q; Du JZ; Yao XQ
Biomaterials; 2022 Nov; 290():121827. PubMed ID: 36228517
[TBL] [Abstract][Full Text] [Related]
30. Lymphoid enhancer-binding factor 1, a representative of vertebrate-specific Lef1/Tcf1 sub-family, is a Wnt-beta-catenin pathway target gene in human endothelial cells which regulates matrix metalloproteinase-2 expression and promotes endothelial cell invasion.
Planutiene M; Planutis K; Holcombe RF
Vasc Cell; 2011 Dec; 3():28. PubMed ID: 22168911
[TBL] [Abstract][Full Text] [Related]
31. Lymphoid enhancer factor-1 and beta-catenin inhibit Runx2-dependent transcriptional activation of the osteocalcin promoter.
Kahler RA; Westendorf JJ
J Biol Chem; 2003 Apr; 278(14):11937-44. PubMed ID: 12551949
[TBL] [Abstract][Full Text] [Related]
32. The transcription factor LEF1 promotes tumorigenicity and activates the TGF-β signaling pathway in esophageal squamous cell carcinoma.
Zhao Y; Zhu J; Shi B; Wang X; Lu Q; Li C; Chen H
J Exp Clin Cancer Res; 2019 Jul; 38(1):304. PubMed ID: 31296250
[TBL] [Abstract][Full Text] [Related]
33. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
Gao J; Dai C; Yu X; Yin XB; Zhou F
J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108
[TBL] [Abstract][Full Text] [Related]
34. High LEF1 expression predicts adverse prognosis in chronic lymphocytic leukemia and may be targeted by ethacrynic acid.
Wu W; Zhu H; Fu Y; Shen W; Miao K; Hong M; Xu W; Fan L; Young KH; Liu P; Li J
Oncotarget; 2016 Apr; 7(16):21631-43. PubMed ID: 26950276
[TBL] [Abstract][Full Text] [Related]
35. Knockdown of lncRNA LEF1-AS1 inhibited the progression of oral squamous cell carcinoma (OSCC) via Hippo signaling pathway.
Zhang C; Bao C; Zhang X; Lin X; Pan D; Chen Y
Cancer Biol Ther; 2019; 20(9):1213-1222. PubMed ID: 30983488
[TBL] [Abstract][Full Text] [Related]
36. miR-324-3p promotes gastric cancer development by activating Smad4-mediated Wnt/beta-catenin signaling pathway.
Sun GL; Li Z; Wang WZ; Chen Z; Zhang L; Li Q; Wei S; Li BW; Xu JH; Chen L; He ZY; Ying K; Zhang X; Xu H; Zhang DC; Xu ZK
J Gastroenterol; 2018 Jun; 53(6):725-739. PubMed ID: 29103082
[TBL] [Abstract][Full Text] [Related]
37. Optimizations of a novel fluorescence polarization-based high-throughput screening assay for β-catenin/LEF1 interaction inhibitors.
Chen Y; Fu Z; Li D; Yue Y; Liu X
Anal Biochem; 2021 Jan; 612():113966. PubMed ID: 32956692
[TBL] [Abstract][Full Text] [Related]
38. Investigations on the mechanism of progesterone in inhibiting endometrial cancer cell cycle and viability via regulation of long noncoding RNA NEAT1/microRNA-146b-5p mediated Wnt/β-catenin signaling.
Huang X; Zhong R; He X; Deng Q; Peng X; Li J; Luo X
IUBMB Life; 2019 Feb; 71(2):223-234. PubMed ID: 30452118
[TBL] [Abstract][Full Text] [Related]
39. Lymphoid enhancer binding factor-1 (LEF1) expression as a prognostic factor in adult acute promyelocytic leukemia.
Albano F; Zagaria A; Anelli L; Orsini P; Minervini CF; Impera L; Casieri P; Coccaro N; Tota G; Brunetti C; Minervini A; Pastore D; Carluccio P; Mestice A; Cellamare A; Specchia G
Oncotarget; 2014 Feb; 5(3):649-58. PubMed ID: 24378360
[TBL] [Abstract][Full Text] [Related]
40. Odd-skipped related 1 is a novel tumour suppressor gene and a potential prognostic biomarker in gastric cancer.
Otani K; Dong Y; Li X; Lu J; Zhang N; Xu L; Go MY; Ng EK; Arakawa T; Chan FK; Sung JJ; Yu J
J Pathol; 2014 Nov; 234(3):302-15. PubMed ID: 24931004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
